Skip to main content
Premium Trial:

Request an Annual Quote

BGI Europe, NIM Genetics Reach Agreement on NIPT for Spain

NEW YORK (GenomeWeb) — BGI Europe has inked an exclusive technology transfer deal with Spain's NIM Genetics for BGI Europe's non-invasive prenatal testing technology.

The deal allows NIM to begin offering BGI Europe's NIPT in Spain. The test, called TrisoNIM Advance and marketed as Nifty in other parts of Europe, detects the risk of genetic conditions such as Down syndrome from as early as 10 weeks into the pregnancy.

The deal follows other deals forged by BGI Europe, the European branch of BGI, to make Nifty available in Italy and Poland

 

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.